1. CMET-22. CAPMATINIB (INC280) IN METΔEX14-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): EFFICACY DATA FROM THE PHASE 2 GEOMETRY MONO-1 STUDY. (11th November 2019) Authors: Heist, Rebecca S; Seto, Takashi; Han, Ji-Youn; Reguart, Noemi; Garon, Edward B; Groen, Harry J M; Tan, Daniel S W; Hida, Toyoaki; de Jonge, Maja; V Orlov, Sergey; Smit, Egbert F; Souquet, Pierre-Jean; Vansteenkiste, Johan; Le Mouhaer, Sylvie; Robeva, Anna; Waldron-Lynch, Maeve; Giovannini, Monica... Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC. (31st March 2017) Authors: Chaib, Imane; Karachaliou, Niki; Pilotto, Sara; Codony Servat, Jordi; Cai, Xueting; Li, Xuefei; Drozdowskyj, Ana; Servat, Carles Codony; Yang, Jie; Hu, Chunping; Cardona, Andres Felipe; Vivanco, Guillermo Lopez; Vergnenegre, Alain; Sanchez, Jose Miguel; Provencio, Mariano; de Marinis, Filippo; Pa... Journal: Journal of the National Cancer Institute Issue: Volume 109:Number 9(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Common EGFR-mutated subgroups (Del19/L858R) in advanced non-small-cell lung cancer: chasing better outcomes with tyrosine kinase inhibitors. (April 2015) Authors: Reguart, Noemi; Remon, Jordi Journal: Future oncology Issue: Volume 11:Number 8(2015) Page Start: 1245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Diarrhea associated with afatinib: an oral ErbB family blocker. Issue 6 (June 2013) Authors: Yang, James Chih-Hsin; Reguart, Noemi; Barinoff, Jana; Köhler, Jens; Uttenreuther-Fischer, Martina; Stammberger, Uz; O'Brien, Dennis; Wolf, Jürgen; Cohen, Ezra EW Journal: Expert review of anticancer therapy Issue: Volume 13:Issue 6(2013) Page Start: 729 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Diarrhea associated with afatinib: an oral ErbB family blocker. Issue 6 (June 2013) Authors: Yang, James Chih-Hsin; Reguart, Noemi; Barinoff, Jana; Köhler, Jens; Uttenreuther-Fischer, Martina; Stammberger, Uz; O'Brien, Dennis; Wolf, Jürgen; Cohen, Ezra EW Journal: Expert review of anticancer therapy Issue: Volume 13:Issue 6(2013) Page Start: 729 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in the Treatment of Patients with Non-small Cell Lung Cancer of Squamous Histology: Focus on Afatinib. Issue 1 (2021) Authors: Reguart, Noemi; Reyes, Roxana Journal: Touch reviews in oncology & haematology Issue: Volume 17:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis. Issue 10 (October 2018) Authors: Duruisseaux, Michäel; Martínez-Cardús, Anna; Calleja-Cervantes, Maria E; Moran, Sebastian; Castro de Moura, Manuel; Davalos, Veronica; Piñeyro, David; Sanchez-Cespedes, Montse; Girard, Nicolas; Brevet, Marie; Giroux-Leprieur, Etienne; Dumenil, Coraline; Pradotto, Monica; Bironzo, Paolo; Capellett... Journal: Lancet Issue: Volume 6:Issue 10(2018) Page Start: 771 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Exercise in lung Cancer, the healthcare providers opinion (E.C.H.O.): Results of the EORTC lung cancer Group (LCG) survey. (July 2022) Authors: Pilotto, Sara; Avancini, Alice; Menis, Jessica; Sperduti, Isabella; Giaj Levra, Matteo; Berghmans, Thierry; Bironzo, Paolo; Brandão, Mariana; De Ruysscher, Dirk; Edwards, John; Faivre-Finn, Corinne; Girard, Nicolas; Greillier, Laurent; Hendriks, Lizza; Lantuejoul, Sylvie; Mauer, Murielle; Novello... Journal: Lung cancer Issue: Volume 169(2022) Page Start: 94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. GLASS: Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study: real world data of 123 NSCLC patients. (October 2020) Authors: Peled, Nir; Gillis, Roni; Kilickap, Saadettin; Froesch, Patrizia; Orlov, Sergei; Filippova, Elena; Demirci, Umut; Christopoulos, Petros; Cicin, Irfan; Basal, Fatma Bugdayci; Yilmaz, Cengiz; Fedor, Moiseenko; Korkmaz, Taner; Paydas, Semra; Gautschi, Oliver; Zirtiloglu, Alisan; Eralp, Yesim; Cinkir... Journal: Lung cancer Issue: Volume 148(2020) Page Start: 48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Integral mediastinal staging in patients with NON-SMALL cell lung cancer and risk factors for occult N2 disease. (March 2023) Authors: Lucena, Carmen M.; Martin-Deleon, Roberto; Boada, Marc; Marrades, Ramon M.; Sánchez, David; Sánchez, Marcelo; Vollmer, Ivan; Martínez, Daniel; Fontana, Ainhoa; Reguart, Noemi; Molins, Laureano; Agustí, Carlos Journal: Respiratory medicine Issue: Volume 208(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗